Keyphrases
Aldosterone Antagonists
16%
All-cause Mortality
50%
Atrial Fibrillation
16%
Beta-blockers
16%
Cardiovascular Hospitalizations
16%
Cardiovascular Mortality
50%
Chronic Obstructive Pulmonary Disease
16%
Clinical Characteristics
16%
Confidence Interval
50%
Estimated Glomerular Filtration Rate
16%
Heart Failure Hospitalization
16%
Heart Failure with Preserved Ejection Fraction (HFpEF)
50%
Hypertension
16%
Ischemic Heart Disease
16%
Long-term Prognosis
100%
Male Gender
16%
Meta-analysis
100%
Patients with Heart Failure
100%
Reduced Ejection Fraction
100%
Renin-angiotensin System Inhibitors
16%
Risk Ratio
66%
Study Support
16%
Systematic Meta-analysis
100%
Pharmacology, Toxicology and Pharmaceutical Science
Aldosterone Antagonist
33%
All Cause Mortality
100%
Atrial Fibrillation
33%
Beta Adrenergic Receptor Blocking Agent
33%
Cardiovascular Mortality
100%
Chronic Obstructive Lung Disease
33%
Congestive Heart Failure
100%
Heart Failure with Preserved Ejection Fraction
33%
Heart Failure with Reduced Ejection Fraction
33%
Ischemic Heart Disease
33%
Observational Study
33%
Renin-Angiotensin System Inhibitor
33%
Medicine and Dentistry
Aldosterone Antagonist
6%
All Cause Mortality
18%
Atrial Fibrillation
6%
Beta Adrenergic Receptor Blocking Agent
6%
Cardiovascular Mortality
18%
Chronic Obstructive Pulmonary Disease
6%
Congestive Heart Failure
100%
Ejection Fraction
100%
Glomerular Filtration Rate
6%
Heart Failure with Preserved Ejection Fraction
6%
Heart Failure with Reduced Ejection Fraction
6%
Ischemic Heart Disease
6%
Meta-Analysis
100%
Observational Study
6%
Renin-Angiotensin System Inhibitor
6%
Systematic Review
100%
Biochemistry, Genetics and Molecular Biology
Aldosterone
5%
All Cause Mortality
16%
Atrial Fibrillation
5%
Beta Blocker
5%
Cardiovascular Mortality
16%
Glomerulus Filtration
5%
Heart Ejection Fraction
100%
Observational Study
5%
Renin Angiotensin Aldosterone System
5%